Genovis AB

The Swedish business Genovis AB is involved in the creation, production, and sale of tools and equipment for cellular research. The two product portfolios that the company offers are the protein portfolio and the nano portfolio.

The protein portfolio creates products for autoimmune, inflammatory, and cancerous illnesses. The portfolio includes IgGZERO, a protein that preferentially cleaves the sugar molecules found naturally on antibodies, and FabRICATOR, a genetically modified enzyme that splits antibodies in half. The preclinical market is the target market for the majority of the nano portfolio's goods. Through dealers and distributors throughout the continents of Europe, North America, and Asia, the company markets and sells its goods. It ran Eijdo Research AB, a fully owned subsidiary, as of December 31, 2011.

Scientists from all around the world employ Genovis enzyme products, also known as SmartEnzymes, and the cutting-edge product formats simplify the creation and quality assurance of biological therapies. Genovis AB is one of the largest biotech companies in Sweden is BioInvent.

Founded: 1999

Number of employees: over 20 employees

Headquarters: Lund, Sweden

Website: https://www.genovis.com/